A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe

A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe

Post-marketing surveillance of Rosuvastatin/Ezetimibe

This study will collect clinical data, mainly focused on safety, in Korean population as per the requirement of MFDS for market authorization.

Inclusion Criteria:

• The patient who is first prescribed and administered Rosuvastatin/Ezetimibe

Exclusion Criteria:

• The patients who are overreacting to this drug or its components
• The patients with severe renal impairment